Myriad Genetics Inc (MYGN) — Cash Flow Quality Index
Myriad Genetics Inc (MYGN) has a Cash Flow Quality Index of -1.60x as of September 2021. Operating cash flow of $-39.30 Million is below net income of $24.60 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore how efficiently does Myriad Genetics Inc generate cash to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Myriad Genetics Inc Cash Flow Quality Index (2008–2020)
Historical Cash Flow Quality Index for Myriad Genetics Inc across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Myriad Genetics Inc (MYGN) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Myriad Genetics Inc (2008–2020)
Year-by-year earnings quality comparison for Myriad Genetics Inc. For live market cap and the full company financial profile, see Myriad Genetics Inc (MYGN) total market value.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2020 | 18.20x | $83.70 Million | $4.60 Million | ▲ +0.0% |
| 2019 | 18.20x | $83.70 Million | $4.60 Million | ▲ +1992.7% |
| 2018 | 0.87x | $115.90 Million | $133.30 Million | ▼ -85.8% |
| 2017 | 6.10x | $106.20 Million | $17.40 Million | ▲ +330.1% |
| 2016 | 1.42x | $166.30 Million | $117.20 Million | ▼ -19.0% |
| 2015 | 1.75x | $140.50 Million | $80.20 Million | ▲ +62.3% |
| 2014 | 1.08x | $190.20 Million | $176.20 Million | ▼ -8.6% |
| 2013 | 1.18x | $173.90 Million | $147.20 Million | ▼ -6.6% |
| 2012 | 1.26x | $141.80 Million | $112.15 Million | ▼ -2.7% |
| 2011 | 1.30x | $130.83 Million | $100.71 Million | ▲ +27.6% |
| 2010 | 1.02x | $155.09 Million | $152.30 Million | ▲ +2.5% |
| 2009 | 0.99x | $84.04 Million | $84.61 Million | ▼ -54.2% |
| 2008 | 2.17x | $103.74 Million | $47.84 Million | — |